<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(2)</volume><submitter>Nauck MA</submitter><funding>Novo Nordisk</funding><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><journal>Diabetes care</journal><pagination>e30-e31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7411284</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.</pubmed_title><pmcid>PMC7411284</pmcid><funding_grant_id>UC4 DK108612</funding_grant_id><funding_grant_id>UL1 TR002489</funding_grant_id><funding_grant_id>U01 DK098246</funding_grant_id><funding_grant_id>U54 DK118612</funding_grant_id><pubmed_authors>Saevereid HA</pubmed_authors><pubmed_authors>Rasmussen S</pubmed_authors><pubmed_authors>Buse JB</pubmed_authors><pubmed_authors>Kreiner E</pubmed_authors><pubmed_authors>Nauck MA</pubmed_authors><pubmed_authors>LEADER Trial Investigators</pubmed_authors></additional><is_claimable>false</is_claimable><name>Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Feb</publication><modification>2025-04-27T01:18:23.576Z</modification><creation>2025-02-19T01:10:24.904Z</creation></dates><accession>S-EPMC7411284</accession><cross_references><pubmed>31959650</pubmed><doi>10.2337/dci19-0067</doi></cross_references></HashMap>